Experimental hyperprolactinemia in a rat model: Alteration in centrally mediated neuroerectile mechanisms

International Journal of Impotence Research

Volumn 12, Issue 1, 2000, Pages 23-32

  Rehman, J ^b   Christ, G ^b   Alyskewycz, M ^b   Kerr, E ^b   Melman, A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Erectile dysfunction; Hyperprolactinemia; Penile reflexes; Prolactin

Indexed keywords

PAPAVERINE; PROLACTIN; SESAME SEED OIL; TESTOSTERONE PROPIONATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; ELECTROSTIMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERECTILE DYSFUNCTION; HYPERPROLACTINEMIA; MALE; MUSCLE DEVELOPMENT; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PENIS ERECTION; PERIPHERAL NERVOUS SYSTEM; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RADIOIMMUNOASSAY; RAT; REFLEX; TESTOSTERONE BLOOD LEVEL;

EID: 0033916060     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900473     Document Type: Article

References (65)

1. Drago F. Prolactin and sexual behavior: a review. Neurosci Behav Rev 1984; 8: 433-439.
2. Sarapura V, Schlaff WD. Recent advances in the understanding of the pathophysiology and treatment of hyperprolactinemia. Curr Opin Obstet Gynecol 1993; 5: 360-367.
3. Sobrinho LG. The psychogenic effects of prolactin. Acta Endocrinol 1993; 129: 38-40.
4. Buvat J et al. Hyperprolactinaemia and sexual function in males. Hormone Res 1985; 22: 196-203.
5. Bagdy G, Makara GB. Paraventricular nucleus controls 5-HT2C receptor-mediated corticosterone and prolactin but not oxytocin and penile erection responses. Eur J Pharmacol 1995; 275: 301-305.
6. Selmanoff M et al. Tyrosine hydroxylase and POMC mRNA in the arcuate region are increased by castration and hyperprolactinemia. Mol Brain Res 1991; 10: 277-281.
7. Toubeau G, Deselin I, Parmentier M, Pasteels L. Immunocytochemical localization of prolactin-containing neurons in the rat hypothalamus. Ann Endocrinol (Paris) 1980; 41: 137-138.
8. Aoki H et al. Suppression by prolactin of the electrically induced erectile response through its direct effect on the corpus cavernosum penis in the dog. J Urol 1995; 154: 595-600.
9. Sacks BD, Garinello LD. Interaction between penile reflexes and copulation in male rats. J Comp Physiol 1978; 92: 759-767.
10. Sachs B, Baum MJ, Melman A. Normal sexual behaviour and penile reflexes in long term diabetic male rats. Arch Androl 1982; 9: 351-353.
11. Murray FT et al. Erectile and copulatory dysfunction in chronically diabetic BB/WOR rats. Am J Physiol 1992; 263: E151-157.
12. Quinlan DM et al. The rat as a model for the study of penile erection. J Urol 1989; 141: 656-661.
13. Martinez-Pineiro L et al. Rat model for the study of penile erection: pharmacologic and electrical-stimulation parameters. Eur Urol 1994; 25: 62-70.
14. Rehman J et al. Diminished neurogenic but not pharmacological erections in the 2-to 3-month experimentally diabetic rat. Am J Physiol 1997; H1960-H1971.
15. Matthews MK, Adler NT. Systematic interrelationship mating, vaginal plug deposition and sperm transport in the rat. Physiol Behav 1978; 20: 303-307.
16. Hart BL, Melese-d'hospital PY. Penile mechanisms and the role striated penile muscles in penile reflexes. Physiol Behav 1981; 31: 807-813.
17. Sachs BD. Role of striated penile muscles in penile reflexes, copulation and induction of pregnancy in the rat. J Reprod Fertil 1982; 66: 433-443.
18. Wallach SJR, Hart BL. The role of striated penile muscles of the male rat in the seminal plug dislodgement and deposition. Physiol Behav 1983; 31: 815-821.
19. Govier FE, McClure RD, Kramer-Levien D. Endocrine screening for sexual dysfunction using free testosterone determinations. J Urol 1996; 156: 405-408.
20. Faiman C. Endocrine causes of impotence. Cleveland Clinic J Med 1993; 60: 428-429.
21. Jones TH. The management of hyperprolactinaemia. Br J Hospital Med 1995; 53: 374-378.
22. Soule SG, Jacobs HS. Prolactinomas: present day management. Br J Obstet Gynaecol 1995; 102: 178-181.
23. Guay AT, Sabharwal P, Varma S, Malarkey WB. Delayed diagnosis of psychological erectile dysfunction because of the presence of macroprolactinemia. J Clin Endocrinol Metab 1996; 81: 2512-2514.
24. Maeda N, Matsuoka N, Yamaguchi I. Role of the dopaminergic, serotonergic and cholinergic link in the expression of penile erection in rats. Japan J Pharmacol 1994; 66: 59-66.
25. Yang JY, Pan JT. Enhanced tuberoinfundibular dopaminergic neuron activity in thyroidectomized, ovariectomized and estrogen-treated rats with hyperprolactinemia. Neuroendocrinol 1994; 59: 520-527.
26. Doppler W. Regulation of gene expression by prolactin [review]. Rev Physiol Biochem Pharmacol 1994; 124: 93-130.
27. Hull EM et al. Dopaminergic control of male sex behavior in rats: Effects of an intracereberly infused agonist. Brain Res 1986; 370: 73-81.
28. Kalra PS, Simpkhis JW, Iuttge WG, Karla SP. Effects on male sex behavior and preoptic dopamine neurons at hyperprolactinemia induced by MtTW15 pituitary tumors. Endocrinology 1983; 113: 2065-2071.
29. Kruse A, Astrup J, Gyldensted C, Cold GE. Hyperprolactinaemia in patients with pituitary adenomas. The pituitary stalk compression syndrome. Br J Neurosurg 1995; 9: 453-457.
30. Aron DC, Tyrrell JB, Wilson CB. Pituitary tumors. Current concepts in diagnosis and management. Western J Med 1995; 162: 340-352.
31. Molitch ME. Pathologic hyperprolactinemia. Endocrinol Metabol Clinics of North Am 1992; 21: 877-901.
32. Schlechte JA. Clinical impact of hyperprolactinaemia. Baillieres Clin Endocrinol Metab 1995; 9: 359-366.
33. Fish LH, Mariash CN. Hyperprolactinemia, infertility and hypothyroidism. Arch Int Med 1988; 148: 709-711.
34. Blackwell RE. Hyperprolactinemia. Evaluation and management. Endocrinol Metab Clinics of North Am 1992; 21: 105-124.
35. Vanderpump MP, Tunbridge WM. The effects of drugs on endocrine function [review]. Clin Endocrinol 1993; 39: 389-397.
36. Peillon F. Functional hyperprolactinemia. Curr Therap Endocrinol Metab 1994; 5: 37-41.
37. Dutt A, Kaplitt MG, Kow LM, Pfaff DW. Prolactin, central nervous system and behavior: a critical review. Neuroendocrinology 1994; 59: 413-419.
38. Cunningham GR, Karacan I, Ware JC. The relationship between serum testosterone and prolactin levels and nocturnal penile tumescence (NPT) in impotent men. J Androl 1982; 3: 241-245.
39. Yasumoto R et al. Classification of patterns of nocturnal penile tumescence with continuous monitoring of penile rigidity: analysis of various factors affecting erection. Hinyokika Kiyo - Acta Urologica Japonica 1996; 42: 285-288.
40. Carter JN, Tyson JE, lolls G. Prolactin secreting tumours and hypogonadism in 22 men. New Engl J Med 1978; 299: 847-852.
41. Perryman RL, Thorner MO. The effects of hyperprolactinemia on sexual and reproductive function in men. J Androl 1981; 233-242.
42. Drago F, Pellegrini-Quarantitti B, Scapagnini U, Gesa GL. Short term endogenous hyperprolactinemia and sexual behavior in the male rats. Physiol Behav 1981; 26: 277-279.
43. Bancroft J, O'Carrol R, McNeilly A, Shaw RW. The effects of bromocriptine on the sexual behaviour of hyperprolactinemic man: acontrolled case study. Clin Endocrinol 1984; 21: 131-137.
44. Schwartz MF, Banman IE, Masters WH. Hyperprolactinemia and sexual dysfunction in men. Biol Psych 1982; 17: 861-876.
45. Bartke A et al. Effects of estrogen-induced hyperprolactinemia on endocrine and sexual functions in adult male rats. Neuroendocrinology 1984; 39: 126-135.
46. Clark JT, Kalra PS. Effects on penile reflexes mid plasma hormones of hyperprolactinemia induced by MITW 15 rumors. Hormone Behav 1985; 19: 304-310.
47. Doherty PC, Baum MJ, Todd BR. Effects of chronic hyperprolactinaemia on sexual arousal and erectile function in male rats. Neuroendocrinology 1986; 42: 368-375.
48. Kwan M et al. The nature of androgen action on male sexuality: a combined laboratory self-report study on hypogonadal men. J Clin Endocrinol Metab 1983; 57: 557-562.
49. Bouchard P, Lagoguey M, Brailly S, Schaison C. Gonadotrophin releasing hormone pulsatile administration restores luteinising hormone pulsatility and normal testosterone levels in males with hyperprolactinaemia. J Clin Endocrinol Metab 1985; 60: 258-262.
50. Park SK, Selmanoff M. Hyperprolactinemia suppresses the luteinizing hormone responses to N-methyl-D-aspartate, epinephrine, and neuropeptide-Y in male rats. Endocrinology 1993; 133: 2091-2097.
51. Park SK, Keenan MW, Selmanoff M. Graded hyperprolactinemia first suppresses LH pulse frequency and then pulse amplitude in castrated male rats. Neuroendocrinology 1993; 58: 448-453.
52. Merchenthaler I et al. Induction of proenkephalin in tuberoinfundibular dopaminergic neurons by hyperprolactinemia: the role of sex steroids. Endocrinology 1995; 136: 2442-2450.
53. Genazzani AD et al. The duration of prolactin secretory bursts from the pituitary is independent from both prolactin and gonadal steroid plasma levels in women and in men. J Endocrinol Invest 1994; 17: 83-89.
54. Isurugi K, Kajiwara T, Hosaka Y, Minowada S. Successful gonadotrophin treatment of hypogonadism in postoperative patients with macroprolactinoma and persistent hyperprolactinaemia. Int J Androl 1993; 16: 306-310.
55. Merola B et al. Effectiveness and long-term tolerability of the slow release oral form of bromocriptine on tumoral and nontumoral hyperprolactinemia. J Endocrinol Invest 1992; 15: 173-176.
56. Weingrill CO et al. Long-acting oral bromocriptine (Parlodel SRO) in the treatment of hyperprolactinemia. Fertil Steril 1992; 57: 331-335.
57. Zgliczynski W et al. New long-acting bromocriptine (Parlodel MR and Parlodel LAR) in the treatment of pituitary tumours with hyperprolactinemia. Endokrynol Polska 1992; 43: 234-241.
58. Ciccarelli E et al. Double blind randomized study using oral or injectable bromocriptine in patients with hyperprolactinaemia. Clin Endocrinol 1994; 40: 193-198.
59. Boisvert P, Brisson GR, Peronnet F, Gareau R. Acute administration of bromocriptine abolishes the hyperprolactinemic response induced by submaximal exercise in man. Can J Physiol Pharmacol 1992; 70: 1379-1383.
60. Besser GM, Thorner MO. Bromocriptine in the treatment of the hyperprolactinaemia hypogonadism syndromes. Postgrad Med J 1976; 52: 64-70.
61. Martikainen H, Vinko F. HCG stimulation of testicular steroidogenesis during induced hyper and hypoprolactinaemia in man. Clin Endocrinol 1982; 16: 227-234.
62. Magrini G, Ebiner JR, Burchardt P, Felber JP. Study on the relationship between plasma prolactin levels and androgen metabolism in man. J Clin Endocrinol Metab 1976; 43: 944-947.
63. Doherty PCA, Burke MP, Klemeke HH, Smith MS. Effects of hyperprolactinemia on copulatory behavior and testicular human chorionic gonadotropin binding in adrenalectomized rats. Endocrinology 1982; 111: 820-826.
64. Hart BL. Sexual reflexes and mating behavior in the male rat. Camp Physiol Psychol 1968; 65: 453-460.
65. Hart BL. Role of testosterone secretion and penile reflexes in sexual behavior and sperm competition in male rats: A theoretical contribution. Physiol Behav 1983; 31: 823-827.